Loading...
Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis
Anti‐diabetic agent‐related hypoglycemia is a serious complication in type 2 diabetic patients on hemodialysis. Therefore, we assessed the efficacy and tolerability of 24 weeks of monotherapy with vildagliptin, a dipeptidyl peptidase four inhibitor, which is a new class of antidiabetic agent. This o...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014953/ https://ncbi.nlm.nih.gov/pubmed/24843580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00169.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|